The U.S. Environmental Protection Agency, under the Trump Administration, is continuing its appeal in the fluoride case but has elected to focus its arguments on legal grounds for reversal rather than asking the appellate court to revisit the district court's factual findings on the underlying science. This strategic choice, highlighted in Bergeson & Campbell's June 2026 federal developments roundup, carries meaningful implications for chemical and environmental regulation, and for the compliance posture of regulated clients operating in this space.
By declining to challenge the lower court's scientific record, the EPA effectively preserves those factual determinations on appeal and instead asks the reviewing court to evaluate the legal framework that produced the outcome below. This is a notable posture in litigation under the Toxic Substances Control Act (TSCA), where the interplay between scientific evidence and statutory interpretation often dictates the scope of agency authority. An appellate decision focused on legal questions rather than scientific weight could clarify the standard of review applicable to chemical risk determinations and shape how courts evaluate similar TSCA challenges in the future.
For regulated industries, the implications extend beyond fluoride itself. The appeal signals that the current administration may continue to test the legal contours of chemical risk assessments without disturbing the evidentiary records developed in trial courts. Clients managing TSCA compliance obligations, evaluating risk determinations, or anticipating enforcement exposure should consider how a ruling on the legal framework could influence the durability of agency findings, the burden of proof in subsequent matters, and the procedural pathways available to challenge or defend regulatory action.
More broadly, the Bergeson & Campbell June 2026 roundup tracks a range of federal chemical, environmental, and regulatory developments that warrant monitoring. Companies subject to TSCA, environmental permitting, or related regimes should incorporate these signals into their compliance reviews, risk-management planning, and litigation readiness. Counsel should pay particular attention to how courts respond to the EPA's narrowed appellate theory and whether emerging decisions reshape expectations for scientific deference and agency discretion.
This article is provided for general informational purposes only and does not constitute legal advice. Clients facing specific regulatory or compliance questions should seek tailored guidance from qualified counsel.